Product Information
TIAGABINE HCL 4 MG TABLET is a generic product labeled by Novadoz Pharmaceuticals LLC, priced at $2.2734 per EA under NDC 72205008530. Its NADAC has been published 221 times since Jun 1, 2022.
FDA first approved this application on Nov 16, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 mg/1
Manufacturer
Novadoz Pharmaceuticals LLCNDC
72205008530
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TIAGABINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214816FDA Approved
11/16/2021
TE Code
AB
On Market Since
11/23/2021
Pharmacological Classes
Price Statistics
The NADAC for TIAGABINE HCL 4 MG TABLET has been published 221 times since Jun 1, 2022, and over the history we have for it it has declined 35.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.2734 per EA |
|---|---|
| All-time high | $3.5221 (Jul 13, 2022) |
| All-time low | $1.6211 (Nov 19, 2025) |
| 52-week high | $2.2734 |
| 52-week low | $1.6211 |
| Median price | $2.3427 |
| Average price | $2.4736 |
| Largest weekly change | +43.0% (Mar 20, 2024) |
| Weeks tracked | 221 |
| Tracking since | Jun 1, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TIAGABINE HCL 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TIAGABINE HCL 4 MG TABLET, manufactured by Novadoz Pharmaceuticals LLC, is $2.2734 per EA (NDC 72205008530), effective Aug 19, 2026.
How has the price of TIAGABINE HCL 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for TIAGABINE HCL 4 MG TABLET has declined 35.5%. It has been tracked across 221 weekly CMS publications since Jun 1, 2022.
What are the highest and lowest recorded NADAC prices for TIAGABINE HCL 4 MG TABLET?
Since Jun 1, 2022, the NADAC for TIAGABINE HCL 4 MG TABLET has ranged from a low of $1.6211 (Nov 19, 2025) to a high of $3.5221 (Jul 13, 2022), with a median of $2.3427 per EA.
Are there cheaper alternatives to TIAGABINE HCL 4 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TIAGABINE HCL 4 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TIAGABINE HCL 4 MG TABLET?
TIAGABINE HCL 4 MG TABLET (NDC 72205008530) is labeled by Novadoz Pharmaceuticals LLC, and CMS classifies it as a generic product.